Medical Device Cleaning Market Insights and Industry Analysis by Process (Disinfection [High-level Disinfectants, Intermediate-level Disinfectant, Low-level Disinfectant], Automatic Cleaning [Enzymatic Detergents, Non-Enzymatic Detergents], Manual Cleaning [Enzymatic, Non-Enzymatic], Presoak/Precleaning [Enzymatic, Non-Enzymatic]), Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Dental Instruments, Other Instruments), End Users (Hospitals and Clinics, Diagnostic Centers, Dental Clinics and Hospitals, Other End Users), and by Region (North America, Europe, Asia-Pacific, Middle East & Africa, and South America), Competitive Market Size, Share, Trends, and Forecast to 2026
July 06, 2021 12:00 ET | Source: Market Research Future
New York, US, July 06, 2021 (GLOBE NEWSWIRE) — Medical Device Cleaning Market Overview:
According to a comprehensive research report by Market Research Future (MRFR), “Medical Device Cleaning Market Information by Process, Application, End Users, and Region – Forecast till 2026”, the market is projected to cross USD 4.1 Billion by 2026 at 7.2% CAGR.
After a specific use, medical instruments must be sterile. This is done for the purpose of ensuring patient safety and preventing infections at the wound and incision sites. Cleaning surgical tools is also a more important and critical chore than cleaning non-medical gadgets. Surgical equipment is contaminated with blood, organic materials, pus, tissue, and other contaminants that could spread infection to others if reused. As a result, medical device cleaning agents are used to clean and disinfect medical instruments.
The medical device cleaning market is expected to grow significantly over the forecast period, owing to factors such as an increase in the number of surgical procedures, an increase in the number of covid-19 patients, an increase in the number of private and public hospitals, and an increase in the availability of disinfectants for surgical products, among others. The strong need for developing competitors to enter the disinfection industry is projected to be fueled by the rising demand for disinfectants. This reduces the risk of a new player entering the global medical device cleaning industry.
A growing number of patients with chronic diseases, a growing geriatric population, a growing number of private and public hospitals, a growing number of regulatory requirements and compliance, a growing number of surgical procedures, growing government investments to improve primary healthcare infrastructure, and rising patient healthcare expenditure.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/10582
Medical Device Cleaning Market Competitive Landscape:
The major players operating in the Global Medical Device Cleaning Market are
- 3M Company (US)
- Advanced Sterilization Products (US)
- Pharmax Ltd. (Canada)
- Stryker Corporation (US)
- Medline Industries Inc. (US)
- STERIS plc (US)
- Getinge Group (Sweden)
- Cantel Medical Corporation (US)
- Ecolab Inc. (US)
- Ruhof Corporation (US)
- Metrex Research LLC (US)
- Hartmann Group (Germany)
- Oro Clean Chemie AG (Switzerland)
- Integra LifeSciences Holdings Corporation (US)
- Sklar Surgical Instruments (US)
- Biotrol International (US)
- G9 Chemicals (UK)
- Medalkan (Greece)
- Case Medical Inc. (US)
- Certol International LLC (US)
Concerns about the safety of reprocessed instruments, as well as a rising desire for single-use instruments, will likely function as market limitations for the medical device cleaning industry’s expansion in the forecasted timeframe. Cleaning and disinfection of modern and complex medical devices will become the market’s biggest and most pressing concern.
COVID-19 Analysis Medical Device Cleaning Market
The medical device cleaning market has been damaged by the covid-19 epidemic. The medical equipment industry has not been spared from the pandemic’s effects. Medical device makers, like pharmaceutical businesses, rely heavily on healthcare facilities to obtain data for clinical trials. Many medical device products must go through a series of pre- and post-market clinical investigations before receiving market authorization certificates. Due of the worldwide pandemic, medical device businesses are finding it harder to make educated judgments regarding their products, supply networks, and regulatory duties as the COVID-19 pandemic continues to spread.
Browse In-depth Market Research Report (90 Pages) on Medical Device Cleaning: https://www.marketresearchfuture.com/reports/medical-device-cleaning-market-10582
The market is divided into disinfection, automatic cleaning, manual cleaning, and presoak/precleaning based on the procedure. During the projected period, the automatic cleaning segment is expected to increase at the fastest CAGR. The automatic washer’s increased productivity and the car washer’s reduced time need are the primary aspects driving this segment’s growth in 2020.
The market is divided into surgical instruments, endoscopes, ultrasonography probes, dental tools, and other instruments based on application. Surgical tools, for example, are predicted to account for the highest proportion of the medical device cleaning market by 2020. The rising prevalence and burden of HAIs and chronic diseases, as well as an increase in the number of surgeries, are the key reasons driving the use of surgical instruments, which is likely to drive demand for effective cleaning and disinfection solutions over the forecast period.
The market is divided into diagnostic centers, hospitals and clinics, dental clinics and hospitals, and other end users based on end users. The growing number of clinics and hospitals in developed countries such as the United States and Germany is responsible for the segment’s larger market share. During the forecast period, hospitals and clinics are predicted to grow at the fastest CAGR in the medical device cleaning market.
During the projected period, North America is expected to constitute the largest regional segment of the market. Growing healthcare spending in nations like the United States and Canada, rising senior populations, rising HAI prevalence, a well-established hospital sector, and rising chronic disease occurrences are all factors contributing to the North American region’s high share.
Due to rising healthcare expenditure in countries like India, China, and Japan, the presence of outsourcing organizations, and the unprecedented evolution of healthcare regulations, standards, and infrastructure across the region, Asia Pacific is expected to grow at the highest CAGR in the regional market during the forecast period. Furthermore, the Covid-19 epidemic and the high prevalence of infectious disease are boosting market expansion in this region. One of the important factors driving market expansion during the projection period is the presence of numerous non-government, voluntary, and government organizations focusing on setting infection control standards.
Share your Queries @ https://www.marketresearchfuture.com/enquiry/10582
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact:Market Research FuturePhone:+1 628 258 0071(US) +44 2035 002 764(UK) Email: firstname.lastname@example.orgWebsite: https://www.marketresearchfuture.com
Issue 45 | November 2021 In this issue: Improving the aesthetic appeal of mobility aid devices, tackling counterfeit medical devices amid Covid-19, bioelectric wearables as an alternative to pain management medication, and much more. Read In Browser Medical Devices Global – Digital is monthly Publication covering the latest / future device trends, industry insights alongside…
In this issue: Improving the aesthetic appeal of mobility aid devices, tackling counterfeit medical devices amid Covid-19, bioelectric wearables as an alternative to pain management medication, and much more.
Medical Devices Global – Digital is monthly Publication covering the latest / future device trends, industry insights alongside the biggest mergers and acquisitions globally. We take pride in working with the biggest medical device trade fairs and events globally showcasing our digital publication which is distributed electronically before all major events and shows, internationally.
Our digital publication is designed to educate but also keep our readers up to date with the latest monthly data, facts, and news from across the globe all in one place. We only offer advertises to advertise in our digital publication if we see fit to the editorial coverage for the month – We take pride in working with fewer advertises in the digital publication in exchange for our readers and distribution of the publication at or before major trade fairs across the globe.
If you wish to be considered for advertising opportunities in our digital publication – kindly fill in your details below or email us at Info@medicaldevices-global.com
Read In Browser
Read the magazine for free in your web browser on any device.
Read the magazine for free in your web browser on any device.
Sign up for a free subscription to get each new issue delivered directly to your inbox.
Select an issue from our archive below to read in your web browser.
Select an issue from our archive below to read in your web browser.
ABBOTT EXPANDS PERIPHERAL VASCULAR OFFERINGS WITH ACQUISITION OF WALK VASCULAR, LLC
Abbott Park, III.: Abbott has recently announced that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system…
Abbott Park, III.: Abbott has recently announced that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. Walk Vascular’s peripheral thrombectomy systems will be incorporated into Abbott’s existing endovascular product portfolio. Financial terms were not disclosed.
“The acquisition of Walk Vascular fits well into our leading vascular device offerings and further drives Abbott’s ability to provide one-of-a-kind endovascular therapy solutions to improve patient care,” said Julie Tyler, senior vice president of Abbott’s vascular business. “Walk Vascular’s technology provides physicians with tools to efficiently remove dangerous clots from blood vessels to improve patient care.”
Walk Vascular’s JETi Peripheral Thrombectomy System and next-generation JETi AIO (All In One) Peripheral Thrombectomy System are unique aspiration systems for the removal of intravascular clots, known as thrombus, that can reduce blood flow and lead to serious complications for patients. The innovative JETi systems are designed to break-up and remove clots from the peripheral vascular system while reducing the risk of dislodged clots. The systems are backed by real-world clinical experiences, and Walk is currently enrolling up to 250 patients in the United States and Europe in the JETi Registry.
Ruchika joined Medical Dialogue an Desk Editor for the Business Section in 2019. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate from Delhi University. She can be contacted at email@example.com Contact no. 011-43720751
ViewMind announces developer agreement with HP to help revolutionise the diagnosis and treatment of cognitive disorders
NEW YORK, Aug. 5, 2021 /PRNewswire/ — The medical device, digital health and artificial intelligence company ViewMind, today announces a new deve…
NEW YORK, Aug. 5, 2021 /PRNewswire/ — The medical device, digital health and artificial intelligence company ViewMind, today announces a new development agreement with HP Inc [HPQ]. ViewMind will use HP’s new Reverb G2 Omnicept VR Headset as part of ViewMind’s medical device solution to diagnose and monitor cognitive disorders. By collaborating with HP, ViewMind can rapidly expand, scale and secure global distribution for its award-winning breakthrough technology.
ViewMind has pioneered an affordable, reliable and accessible digital biomarker for cognitive health and will draw on biosensors within the HP Reverb G2 Omnicept VR Headset to track eye movements of patients in response to visual stimulus delivered through the headset. The biometric data recorded is sent to ViewMind’s AI trained algorithms, which enable the screening, diagnosis and monitoring of cognitive disorders.
Alzheimer’s disease pathology commences around 20 years before symptoms. By the time a medical diagnosis occurs, a lot of irreversible damage has occurred. It is therefore imperative to be able to predict accurately who will convert to Alzheimer’s and who will not convert when mild symptoms are first observed. Another area of importance is treatment impact and the ability to measure outcomes and to even screen at the very start of the disease when lifestyle changes and new drug treatments could have the greatest impact on an individual’s cognitive health longevity.
Mark Edwards, CEO ViewMind Inc, “ViewMind are delighted to be collaborating with HP to access the latest innovative HP technologies such as the new HP Reverb G2 Omnicept Edition VR Headset and to ensure ViewMind’s award-winning solution can be accessed across global markets.”
“ViewMind’s technology applies to a range of neurocognitive conditions, an exceptional and unique value proposition. The company is well-poised for massive commercialization success, guaranteeing top-class customer satisfaction and value,” Ojaswi Rana, Best Practices Research Analyst, Frost & Sullivan.
Jay Fraser, Head of XR Developer Relations, “ViewMind choosing the HP Omnicept SDK to tackle some of the major challenges in cognitive health diagnosis highlights HP’s commitment to solutions that can make a significant global and societal impact in digital health.”
ViewMind Inc provides a suite of novel digital biomarker for neurocognitive disorder diagnostics using Artificial Intelligence. ViewMind’s Digital Biomarker’s are reliable, non-invasive, affordable, accessible, and work on individuals independent of culture. To follow ViewMind on LinkedIn, click here.
SOURCE ViewMind Inc
Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post.
Startup Mantra: SaaS ‘Lego bricks’ re-create a smarter workplace
Vaccine makers move quickly against new omicron Covid variant, testing already under way
Network 10 to broadcast Supercars from Albert Park
Lugano NFT Week: Lugano is becoming a Blockchain & Crypto-Friendly City
Google agrees to deeper UK oversight of Privacy Sandbox – TechCrunch
How NASA’s Curiosity Rover Is Making Mars Safer for Astronau
Bosch to invest another $467 million to boost chipmaking capacity – TechCrunch
Amazon and Apple warn of supply chain issues
Job creation roars back in October as payrolls rise by 531,000
GE and Einride unveil first autonomous and electric truck operating on US soil
Press Releases4 months ago
Connecticut comes on board as 19th legal marijuana state
ZDNET7 months ago
New Amazon Fire HD 10 tablets bundle Microsoft 365 and a keyboard case
Ethicalmarkets8 months ago
Join Us in Challenging the Status Quo to Create a More Inclusive, Sustainable Future
Reuters10 months ago
Facebook oversight board overrules company on most cases in first test
Reuters10 months ago
Italy public debt to hit new post-war record in 2021 at 158.5% of GDP – source
Aviation10 months ago
Trapped in ice
CNBC11 months ago
Qualcomm CEO Steve Mollenkopf is retiring, current president to take over
Ventureburn11 months ago
When is the best time to borrow money for your small business? –